At what point do the medical insurance and life insurance...

At what point do the medical insurance and life insurance companies require treatment with procedures such as this BEFORE ventilators are required so as to reduce their exposure to ongoing insurance costs if treatment is delayed? At what point do stakeholders in those entities insist upon that approach?

I think that once (if...) the stem cell treatments are demonstrated to be effective once at the “ventilator stage” (crude concept of treatment options I’m sure), there will come an expectation and financial imperative for insurers to move ahead even of ventilator stage applications. That’s where I personally see the true rocket in application of these therapies and if evidence gathers of mutations with reinfections or simple reinfections the pressures for this scenario will only multiply.

Glad to have got onboard a few weeks ago.

Clearly now is a time for what I say in my standard signature line to be applied moreso than ever - this is not financial advice - do your own research taking into account your own needs and opportunities.